Section: Further learning: Inotropes and vasopressors | ICU upskilling package | Online CPD

Main course page
  • National webinars

    SHPA’s COVID-19 Hospital Pharmacy ICU Upskilling Package offers a collated program of learning to provide rapid upskilling of pharmacist who are new to providing pharmacy services in the intensive care setting.  It provides a brief overview of a critically ill patient, the intensive care environment and some tools to assist in providing a solid foundation clinical overview.  

     All information within the package must be considered and utilised in conjunction with local hospital ICU protocols and guidelines.

    Please note: this package does not feature formalised evaluation or a certificate of completion and information is accurate as of the date of publication or latest review.  It is not intended to be a comprehensive critical care pharmacy training program.

    Reach out to more experienced specialist ICU pharmacists if you are working in isolation.  Utilise your health service network and the SHPA Critical Care Specialty Practice Interest Group discussion forum and SHPA COVID-19 discussion forum.

    COMMONWEALTH OF AUSTRALIA

    Copyright Regulations 1969

    WARNING

    These materials have been reproduced and communicated to you by or on behalf of The Society of Hospital Pharmacists of Australia pursuant to Part VB of the Copyright Act 1968 (the Act).

    This content is protected by copyright laws. Unauthorised use, reproduction or sharing of any part of this content without prior written permission is strictly prohibited.  Any further reproduction or communication of this content by you may be the subject of copyright protection under the Act.

     

Further learning: Inotropes and vasopressors

  • Further learning: Inotropes and vasopressors

    Learning objectives

    • Describe key concepts including mean arterial pressure, systemic vascular resistance and cardiac output
    • Distinguish between types of shock
    • Identify important practice points and relevant clinical pearls for common inotropes and vasopressors
    • Explain the selection of a particular agent in case examples provided
    • Explain overall safety considerations when caring for patients on inotropes or vasopressor infusions